4th Quarter - Report

CROSSROADS STRATEGIES, LLC for BRISTOL-MYERS SQUIBB

Firm
Client
Income
$30,000
Expenses
—

What was lobbied

6 issue areas, each in the filer's own words, with who lobbied on it and where.

Taxation/Internal Revenue Code TAX

Implementation of Tax Cuts and Jobs Act (P.L.115-97).

Contacted: Executive Office of the President (EOP); HOUSE OF REPRESENTATIVES; SENATE; Health & Human Services, Dept of (HHS)

Copyright/Patent/Trademark CPT

Issues related to pharmaceutical patents; S.1416, Affordable Prescriptions for Patients Act of 2019.

Contacted: HOUSE OF REPRESENTATIVES; SENATE; Health & Human Services, Dept of (HHS); Executive Office of the President (EOP)

Bills named: S. 1416 (116th)

Health Issues HCR

Issues related to health care, the Food and Drug Administration (FDA), oncology coverage, 340B Program, drug pricing, and the importation of biopharmaceuticals. Implementation of 21st Century Cures Act (P.L.114-255). S.1895, Lower Health Care Costs Act of 2019.

Contacted: HOUSE OF REPRESENTATIVES; Health & Human Services, Dept of (HHS); SENATE; Executive Office of the President (EOP)

Bills named: S. 1895 (116th)

Medicare/Medicaid MMM

General issues related to Medicare and Medicaid, such as: Part D Medicare Program, Medicare Part B reimbursement, and drug pricing. Proposed Part B IPI Demonstration Project. H.R.3, Lower Drug Costs Now Act of 2019. S.2543, Prescription Drug Pricing Reduction Act of 2019. H.R.19, Lower Costs, More Cures Act of 2019.

Contacted: SENATE; HOUSE OF REPRESENTATIVES; Executive Office of the President (EOP); Health & Human Services, Dept of (HHS)

Bills named: H.R. 3 (116th), S. 2543 (116th), H.R. 19 (116th)

Trade (domestic/foreign) TRD

Issues related to international trade including the United States-Mexico-Canada Agreement (USMCA).

Contacted: SENATE; HOUSE OF REPRESENTATIVES; Health & Human Services, Dept of (HHS); Executive Office of the President (EOP)

Budget/Appropriations BUD

H.R.3164/S.2522, Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2020 and H.R.3055, the FY2020 Consolidated measure; H.R.1865, Further Consolidated Appropriations Act, 2020 (P.L.116-94); Food and Drug Administration (FDA) related issues.

Contacted: Executive Office of the President (EOP); HOUSE OF REPRESENTATIVES; Health & Human Services, Dept of (HHS); SENATE

Bills named: S. 2522 (116th), H.R. 3055 (116th), H.R. 1865 (116th), H.R. 3164 (116th)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.